David L. Graham

Rush-Copley Cancer Care CenterAurora, Illinois - 60504 (217-383-3019) |
- CLINICAL TRIALS 3
- CONDITIONS5
- INTERVENTIONS5
- SINCE2004

Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer
July 2006 - April 2024

Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases
January 2004 - January 2008

Tumor Marker YKL-40 in Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial Cancer Primary Peritoneal Cavity Cancer or Fallopian Tube Cancer Undergoing Chemotherapy
September 2007 -
Prostatic Neoplasms
Neoplasm Metastasis
Ovarian Neoplasms
Peritoneal Neoplasms
Fallopian Tube Neoplasms
Placebo
Laboratory Biomarker Analysis
Zoledronic Acid
Docetaxel
Antiandrogen Therapy



